Replies to post #179 on Esperion Therapeutics Inc (ESPR)

[BuckeyeMike]

Chart looking decent.... MACD upswing...

Presentation on Wednesday, June 7, 2017 at 10:30 a.m. Eastern Time

ANN ARBOR, Mich., May 31, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C), today announced that president and chief executive officer, Tim M. Mayleben, will present at the Jefferies 2017 Global Healthcare Conference in New York City on Wednesday, June 7, 2017 at 10:30 a.m. Eastern Time.

Me thinks they will find & announce Partners (US and Europe/Asia) or be bought out by Big Pharma in the next 6 months...

Either way, I expect the stock to be north of $60 by EOY.